Hamzic-Mehmedbasic Aida, Rasic Senija, Rebic Damir, Durak-Nalbantic Azra, Muslimovic Alma, Dzemidzic Jasminka
University Clinical Centre Sarajevo, Nephrology Clinic, Sarajevo, Bosnia and Herzegovina.
University Clinical Centre Sarajevo, Clinic for Heart Disease and Rheumatism, Sarajevo, Bosnia and Herzegovina.
Med Arch. 2015 Apr;69(2):77-80. doi: 10.5455/medarh.2015.69.77-80. Epub 2015 Apr 6.
The objective of this study was to evaluate prognostic impact of clinical factors on outcome of renal function in septic and non-septic acute kidney injury (AKI) patients.
The prospective, observational, clinical study was performed at Nephrology Clinic and Clinic for Infectious Diseases, University Clinical Centre Sarajevo. One hundred patients with diagnosis of AKI were enrolled in the study, and divided into two groups: septic and non-septic AKI patients. Clinical parameters included causes and type of AKI, pre-existing comorbidities and different treatment modalities. Patients were followed up until discharge or death. Renal function outcome was defined by creatinine clearance values at discharge.
Septic AKI patients had significantly longer hospital stay (p=0.03), significantly worse renal function outcome (p<0.001), and higher burden of comorbidities (70.6% vs. 60.6%), compared to non-septic patients. Septic AKI patients were almost three times less likely to receive renal replacement therapy (8.8% vs. 24.4%) and they had significant delay in initiation of dialysis (p=0.03). By multivariate analysis, sepsis (95% CI 0.128-0.967, p=0.043) and hypertension (95% CI 0.114-0.788, p=0.015) were independent predictors of adverse renal function outcome in AKI patients. Postrenal type of AKI was independent predictor of renal function recovery in non-septic AKI patients (95% CI 1.174-92.264, p=0.035), while Failure, as third class of AKI, was independent predictor of non-recovered renal function only in septic AKI patients (95% CI 0.026 to 0.868, p=0.034).
Septic AKI patients are clinically distinct compared to non-septic AKI patients with different prognostic factors and poorer renal function outcome.
本研究的目的是评估临床因素对脓毒症和非脓毒症急性肾损伤(AKI)患者肾功能结局的预后影响。
这项前瞻性、观察性临床研究在萨拉热窝大学临床中心的肾脏病诊所和传染病诊所进行。100例诊断为AKI的患者被纳入研究,并分为两组:脓毒症和非脓毒症AKI患者。临床参数包括AKI的病因和类型、既往合并症以及不同的治疗方式。对患者进行随访直至出院或死亡。肾功能结局通过出院时的肌酐清除率值来定义。
与非脓毒症患者相比,脓毒症AKI患者的住院时间显著更长(p=0.03),肾功能结局显著更差(p<0.001),合并症负担更高(70.6%对60.6%)。脓毒症AKI患者接受肾脏替代治疗的可能性几乎是非脓毒症患者的三分之一(8.8%对24.4%),并且他们开始透析的时间显著延迟(p=0.03)。通过多因素分析,脓毒症(95%CI 0.128 - 0.967,p=0.043)和高血压(95%CI 0.114 - 0.788,p=0.015)是AKI患者肾功能不良结局的独立预测因素。肾后性AKI类型是非脓毒症AKI患者肾功能恢复的独立预测因素(95%CI 1.174 - 92.264,p=0.035),而作为AKI第三类的衰竭,仅是脓毒症AKI患者肾功能未恢复的独立预测因素(95%CI 0.026至0.868,p=0.034)。
与非脓毒症AKI患者相比,脓毒症AKI患者在临床上具有不同的预后因素和更差的肾功能结局。